Joseph R. Sherbotie, MD

Dr. Sherbotie received his medical degree from Pennsylvania State University, completed his pediatric residency at Brown University, and completed his pediatric nephrology fellowship at The Children's Hospital of Philadelphia, St. Christopher's Hospital for Children, and the Hospital of the University of Pennsylvania. Dr. Sherbotie spent the next 7 years as a practicing academic pediatric nephrologist at The Children's Hospital of Philadelphia before accepting his current position is a pediatric nephrologist in the Department of Pediatrics, University of Utah School of Medicine. Dr. Sherbotie and his colleagues actively treat pediatric and adolescent patients with a variety of kidney diseases, hypertension, and renal failure. They supervise provision of all types of acute and chronic dialysis and plasmapheresis, Care for children and adolescents before, during, and after renal transplantation is offered. They provide these services over a broad geographic area, including parts of Idaho, Montana, Nevada, New Mexico, Wyoming as well as Utah.

Dr. Sherbotie is presently Associate Professor of Pediatrics (clinical) at the University of Utah in the division of Pediatric Nephrology and Hypertension. He is medical director of the Pediatric and Adolescent Renal Transplantation Program at Primary Children's Medical Center, and was previously medical director of the Pediatric and Adolescent Dialysis Program at the University of Utah. He has been in active board member of the local organ procurement organization. He has served for an extended time on the Pediatric Residency Selection Committee for the Department of Pediatrics, as well as other academic and hospital committees. He is active in educating other health care providers. In addition, Dr. Sherbotie is active in facilitating education and clinical program development in pediatric nephrology in developing countries.

Dr. Sherbotie’s clinical and research interests are inter-related and include management of hypertension in children and adolescents, atypical hemolytic uremic syndrome, renal and solid organ transplantation and related immunologic processes, and successful transition from pediatrics/adolescent to adult care settings for young patients with chronic kidney disease including renal transplantation.